Many people have been wondering what's going on with the announcement by the Trump administration that Kodak (KODK) has been contracted to produce pharmaceutical APIs here in the US. Let's line up some of the public statements about all this first, and then take a closer look. Here's the press release from Kodak after signing a "Letter of Interest" for a $765 million loan for the deal. They state that:
Once fully operational, Kodak Pharmaceuticals will have the capacity at Eastman Business Park to produce up to 25 percent of active pharmaceutical ingredients used in